An evaluation of Qiagen HPV sign for the detection and genotyping of cervical lesions and oropharyngeal squamous cell carcinomas

Chris Ward, Johanna Pedraza, Kimberley Kavanagh, Ingolfur Johannessen, Kate Cuschieri

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

HPV genotyping is an important tool in the epidemiology and surveillance of HPV associated cancers and for the risk-stratification of HPV infections. HPV sign Genotyping Test (QIAGEN) is a new pyrosequencing assay for the detection and genotyping of HPV. The sensitivity and comparative performance of HPV sign was determined using a sample panel derived from histologically confirmed cervical lesions (cervical intraepithelial neoplasia 2 or worse) and oropharyngeal squamous cell carcinomas. Comparative analysis showed that 80% of cervical intraepithelial neoplasia 2+ and 81% of oropharyngeal squamous cell carcinomas were HPV positive by HPV sign compared to 100% of the cervical intraepithelial neoplasia 2+ and 81% of oropharyngeal squamous cell carcinomas by the digene HPV Genotyping RH Test (RH), and INNO-LiPA HPV Genotyping Extra assay respectively. Fewer genotypes were detected overall by HPV sign than via the relevant comparator assays (10 v 21 for cervical intraepithelial neoplasia 2+; 4 v 9 for oropharyngeal squamous cell carcinomas) and also fewer multiple infections (9 v 28 for cervical intraepithelial neoplasia 2+; 0 v 4 for oropharyngeal squamous cell carcinomas). HPV sign results were more compatible with the comparator assay for the oropharyngeal squamous cell carcinoma samples (100%) than for the cervical samples (73%). These results suggest that HPV sign in its current form is suited to samples that harbour multiple infection.
LanguageEnglish
Pages128-132
Number of pages5
JournalJournal of Virological Methods
Volume207
Early online date9 Jul 2014
DOIs
Publication statusPublished - Oct 2014

Fingerprint

Cervical Intraepithelial Neoplasia
Squamous Cell Carcinoma
Cell
Evaluation
Infection
Sign Test
Epidemiology
Stratification
Genotype
Comparative Analysis
Surveillance
Cancer
Neoplasms

Keywords

  • HPV
  • oropharyngeal squamous cell carcinoma
  • pyrosequencing
  • genotyping
  • cervical

Cite this

@article{9529c4e2c7a647a0b3d84a310600d1dd,
title = "An evaluation of Qiagen HPV sign for the detection and genotyping of cervical lesions and oropharyngeal squamous cell carcinomas",
abstract = "HPV genotyping is an important tool in the epidemiology and surveillance of HPV associated cancers and for the risk-stratification of HPV infections. HPV sign Genotyping Test (QIAGEN) is a new pyrosequencing assay for the detection and genotyping of HPV. The sensitivity and comparative performance of HPV sign was determined using a sample panel derived from histologically confirmed cervical lesions (cervical intraepithelial neoplasia 2 or worse) and oropharyngeal squamous cell carcinomas. Comparative analysis showed that 80{\%} of cervical intraepithelial neoplasia 2+ and 81{\%} of oropharyngeal squamous cell carcinomas were HPV positive by HPV sign compared to 100{\%} of the cervical intraepithelial neoplasia 2+ and 81{\%} of oropharyngeal squamous cell carcinomas by the digene HPV Genotyping RH Test (RH), and INNO-LiPA HPV Genotyping Extra assay respectively. Fewer genotypes were detected overall by HPV sign than via the relevant comparator assays (10 v 21 for cervical intraepithelial neoplasia 2+; 4 v 9 for oropharyngeal squamous cell carcinomas) and also fewer multiple infections (9 v 28 for cervical intraepithelial neoplasia 2+; 0 v 4 for oropharyngeal squamous cell carcinomas). HPV sign results were more compatible with the comparator assay for the oropharyngeal squamous cell carcinoma samples (100{\%}) than for the cervical samples (73{\%}). These results suggest that HPV sign in its current form is suited to samples that harbour multiple infection.",
keywords = "HPV, oropharyngeal squamous cell carcinoma, pyrosequencing, genotyping, cervical",
author = "Chris Ward and Johanna Pedraza and Kimberley Kavanagh and Ingolfur Johannessen and Kate Cuschieri",
year = "2014",
month = "10",
doi = "10.1016/j.jviromet.2014.07.001",
language = "English",
volume = "207",
pages = "128--132",
journal = "Journal of Virological Methods",
issn = "0166-0934",

}

An evaluation of Qiagen HPV sign for the detection and genotyping of cervical lesions and oropharyngeal squamous cell carcinomas. / Ward, Chris; Pedraza, Johanna; Kavanagh, Kimberley; Johannessen, Ingolfur ; Cuschieri, Kate.

In: Journal of Virological Methods, Vol. 207, 10.2014, p. 128-132.

Research output: Contribution to journalArticle

TY - JOUR

T1 - An evaluation of Qiagen HPV sign for the detection and genotyping of cervical lesions and oropharyngeal squamous cell carcinomas

AU - Ward, Chris

AU - Pedraza, Johanna

AU - Kavanagh, Kimberley

AU - Johannessen, Ingolfur

AU - Cuschieri, Kate

PY - 2014/10

Y1 - 2014/10

N2 - HPV genotyping is an important tool in the epidemiology and surveillance of HPV associated cancers and for the risk-stratification of HPV infections. HPV sign Genotyping Test (QIAGEN) is a new pyrosequencing assay for the detection and genotyping of HPV. The sensitivity and comparative performance of HPV sign was determined using a sample panel derived from histologically confirmed cervical lesions (cervical intraepithelial neoplasia 2 or worse) and oropharyngeal squamous cell carcinomas. Comparative analysis showed that 80% of cervical intraepithelial neoplasia 2+ and 81% of oropharyngeal squamous cell carcinomas were HPV positive by HPV sign compared to 100% of the cervical intraepithelial neoplasia 2+ and 81% of oropharyngeal squamous cell carcinomas by the digene HPV Genotyping RH Test (RH), and INNO-LiPA HPV Genotyping Extra assay respectively. Fewer genotypes were detected overall by HPV sign than via the relevant comparator assays (10 v 21 for cervical intraepithelial neoplasia 2+; 4 v 9 for oropharyngeal squamous cell carcinomas) and also fewer multiple infections (9 v 28 for cervical intraepithelial neoplasia 2+; 0 v 4 for oropharyngeal squamous cell carcinomas). HPV sign results were more compatible with the comparator assay for the oropharyngeal squamous cell carcinoma samples (100%) than for the cervical samples (73%). These results suggest that HPV sign in its current form is suited to samples that harbour multiple infection.

AB - HPV genotyping is an important tool in the epidemiology and surveillance of HPV associated cancers and for the risk-stratification of HPV infections. HPV sign Genotyping Test (QIAGEN) is a new pyrosequencing assay for the detection and genotyping of HPV. The sensitivity and comparative performance of HPV sign was determined using a sample panel derived from histologically confirmed cervical lesions (cervical intraepithelial neoplasia 2 or worse) and oropharyngeal squamous cell carcinomas. Comparative analysis showed that 80% of cervical intraepithelial neoplasia 2+ and 81% of oropharyngeal squamous cell carcinomas were HPV positive by HPV sign compared to 100% of the cervical intraepithelial neoplasia 2+ and 81% of oropharyngeal squamous cell carcinomas by the digene HPV Genotyping RH Test (RH), and INNO-LiPA HPV Genotyping Extra assay respectively. Fewer genotypes were detected overall by HPV sign than via the relevant comparator assays (10 v 21 for cervical intraepithelial neoplasia 2+; 4 v 9 for oropharyngeal squamous cell carcinomas) and also fewer multiple infections (9 v 28 for cervical intraepithelial neoplasia 2+; 0 v 4 for oropharyngeal squamous cell carcinomas). HPV sign results were more compatible with the comparator assay for the oropharyngeal squamous cell carcinoma samples (100%) than for the cervical samples (73%). These results suggest that HPV sign in its current form is suited to samples that harbour multiple infection.

KW - HPV

KW - oropharyngeal squamous cell carcinoma

KW - pyrosequencing

KW - genotyping

KW - cervical

UR - http://www.sciencedirect.com/science/article/pii/S0166093414002572

U2 - 10.1016/j.jviromet.2014.07.001

DO - 10.1016/j.jviromet.2014.07.001

M3 - Article

VL - 207

SP - 128

EP - 132

JO - Journal of Virological Methods

T2 - Journal of Virological Methods

JF - Journal of Virological Methods

SN - 0166-0934

ER -